Enhancing cardiac assessments: accurate and efficient prediction of quantitative fractional flow reserve.

IF 4.8 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Frontiers in Bioengineering and Biotechnology Pub Date : 2025-01-27 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1438253
Arshia Eskandari, Sara Malek, Alireza Jabbari, Kian Javari, Nima Rahmati, Behrad Nikbakhtian, Bahram Mohebbi, Seyed Ehsan Parhizgar, Mona Alimohammadi
{"title":"Enhancing cardiac assessments: accurate and efficient prediction of quantitative fractional flow reserve.","authors":"Arshia Eskandari, Sara Malek, Alireza Jabbari, Kian Javari, Nima Rahmati, Behrad Nikbakhtian, Bahram Mohebbi, Seyed Ehsan Parhizgar, Mona Alimohammadi","doi":"10.3389/fbioe.2025.1438253","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obstruction within the left anterior descending coronary artery (LAD) is prevalent, serving as a prominent and independent predictor of mortality. Invasive Fractional flow reserve (FFR) is the gold standard for Coronary Artery Disease risk assessment. Despite advances in computational and imaging techniques, no definitive methodology currently assures clinicians of reliable, non-invasive strategies for future planning.</p><p><strong>Method: </strong>The present research encompassed a cohort of 150 participants who were admitted to the Rajaie Cardiovascular, Medical, and Research Center. The method includes a three-dimensional geometry reconstruction, computational fluid dynamics simulations, and methodology optimization for the computation time. Four patients are analyzed within this study to showcase the proposed methodology. The invasive FFR results reported by the clinic have validated the optimized model.</p><p><strong>Results: </strong>The computational FFR data derived from all methodologies are compared with those reported by the clinic for each case. The chosen methodology has yielded virtual FFR values that exhibit remarkable proximity to the clinically reported patient-specific FFR values, with the MSE of 6.186e-7 and R2 of 0.99 (p = 0.00434).</p><p><strong>Conclusion: </strong>This approach has shown reliable results for all 150 patients. The results are both computationally and clinically user-friendly, with the accumulative pre and post-processing time of 15 min on a desktop computer (Intel i7 processor, 16 GB RAM). The proposed methodology has the potential to significantly assist clinicians with diagnosis.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1438253"},"PeriodicalIF":4.8000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11808135/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1438253","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Obstruction within the left anterior descending coronary artery (LAD) is prevalent, serving as a prominent and independent predictor of mortality. Invasive Fractional flow reserve (FFR) is the gold standard for Coronary Artery Disease risk assessment. Despite advances in computational and imaging techniques, no definitive methodology currently assures clinicians of reliable, non-invasive strategies for future planning.

Method: The present research encompassed a cohort of 150 participants who were admitted to the Rajaie Cardiovascular, Medical, and Research Center. The method includes a three-dimensional geometry reconstruction, computational fluid dynamics simulations, and methodology optimization for the computation time. Four patients are analyzed within this study to showcase the proposed methodology. The invasive FFR results reported by the clinic have validated the optimized model.

Results: The computational FFR data derived from all methodologies are compared with those reported by the clinic for each case. The chosen methodology has yielded virtual FFR values that exhibit remarkable proximity to the clinically reported patient-specific FFR values, with the MSE of 6.186e-7 and R2 of 0.99 (p = 0.00434).

Conclusion: This approach has shown reliable results for all 150 patients. The results are both computationally and clinically user-friendly, with the accumulative pre and post-processing time of 15 min on a desktop computer (Intel i7 processor, 16 GB RAM). The proposed methodology has the potential to significantly assist clinicians with diagnosis.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加强心脏评估:准确有效地定量预测分流储备。
背景:左冠状动脉前降支(LAD)内梗阻是普遍存在的,是死亡率的一个重要且独立的预测因子。有创分数血流储备(FFR)是冠状动脉疾病风险评估的金标准。尽管计算机和成像技术取得了进步,但目前还没有明确的方法可以保证临床医生为未来规划提供可靠的、非侵入性的策略。方法:本研究纳入了Rajaie心血管、医学和研究中心的150名参与者。该方法包括三维几何重建、计算流体动力学模拟和计算时间的方法学优化。本研究分析了四名患者,以展示所提出的方法。临床报道的有创性FFR结果验证了优化模型的有效性。结果:将所有方法得出的计算FFR数据与临床报告的每个病例进行比较。所选择的方法产生的虚拟FFR值与临床报告的患者特异性FFR值非常接近,MSE为6.186e-7, R2为0.99 (p = 0.00434)。结论:该方法对所有150例患者均显示出可靠的结果。结果在计算和临床上都很友好,在台式计算机(Intel i7处理器,16 GB RAM)上累计预处理和后处理时间为15分钟。提出的方法有潜力显著协助临床医生的诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
期刊最新文献
Enhanced comfort and biomechanical performance of ejection seat cushions via optimal double-layer foam design. Quantifying single-cell responses to irradiation in 3D. Hydroxypropyl methylcellulose stearoxy ether hydrogel loaded with aloe vera peel-derived extracellular vesicle mimetics promotes wound healing in diabetic mice. Multiple plant growth-promoting bacteria enhance rice growth in non-grain-converted lands. Editorial: Research on nanomaterials in tumor diagnosis and therapy, volume II.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1